Modified cisplatin/interferon...

Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma

Kaseb, Ahmed O., Shindoh, Junichi, Patt, Yehuda Z., Roses, Robert E., Zimmitti, Giuseppe, Lozano, Richard D., Hassan, Manal M., Hassabo, Hesham M., Curley, Steven A., Aloia, Thomas A., Abbruzzese, Jam
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
119
Language:
english
Journal:
Cancer
DOI:
10.1002/cncr.28209
Date:
September, 2013
File:
PDF, 328 KB
english, 2013
Conversion to is in progress
Conversion to is failed